DESITIN ARZNEIMITTEL GMBH was founded in Berlin in 1919. We developed and successfully introduced the still frequently used Desitin® ointment as our first product.
In 1945, Desitin relocated to Hamburg, where the development and sales of medication for illnesses of the central nervous system (CNS) began. The company became a specialist supplier and competent partner in the treatment of epilepsy and Morbus Parkinson.
Desitin is an independent, medium-sized, specialist pharmaceutical company with approximately 290 staff members, predominantly employed at the Hamburg head office.
Desitin is also financially independent and finances its development and investments with own revenues. As a fully-fledged pharmaceutical company, Desitin produces the majority of its medication in-house.
In all its undertakings Desitin strives to fully comply with legal and ethical standards.